1,204
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Balancing need and risk, supply and demand: Developing a tool to prioritize naloxone distribution

, PhDORCID Icon, , MSW, , MPH, , MS, , PhD, , PhD & , BS show all

References

  • Centers for Disease Control and Prevention (CDC). Opioid data analysis and resources. https://www.cdc.gov/drugoverdose/data/analysis.html. Published 2019. Accessed April 29, 2020.
  • Baltimore City Health Department. Baltimore City Health Commissioner responds to surgeon general’s advisory urging naloxone use. https://health.baltimorecity.gov/news/press-releases/2018-04-04-baltimore-city-health-commissioner-responds-surgeon-general’s. Published 2018. Accessed April 29, 2020.
  • Dodson ZM, Yoo EHE, Martin-Gill C, Roth R. Spatial methods to enhance public health surveillance and resource deployment in the opioid epidemic. Am J Public Health. 2018;108(9):1191–1196.
  • Yates D, Frey T, Montgomery JC. Utilizing risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) scores to prioritize offer of rescue naloxone in an outpatient veteran population: a telephone-based project. Subst Abus. 2018;39(2):182–184.
  • Substance Abuse and Mental Health Services Administration. SAMHSA directing $932 million to nation’s communities through the continuation of its State Opioid Response grant funding | SAMHSA – Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/newsroom/press-announcements/201909041245. Published 2019. Accessed April 29, 2020.
  • Lewis C, Vo H, Fishman M. Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review. Subst Abuse Rehabil. 2017;8:79–95.
  • Baggett TP, Hwang SW, O'Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013;173(3):189–195.
  • Davoli M, Bargagli AM, Perucci CA, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102(12):1954–1959.
  • Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T. High risk of overdose death following release from prison: variations in mortality during a 15-year observation period. Addiction. 2017;112(8):1432–1439.
  • Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–55.
  • Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174
  • Wheeler E, Davidson PJ, Stephen JT, Irwin KS. Community-based opioid overdose prevention programs providing naloxone – United States. Morb Mortal Wkly Rep. 2010;61(6):101–105. 2012
  • Bagley SM, Forman LS, Ruiz S, Cranston K, Walley AY. Expanding access to naloxone for family members: The Massachusetts experience. Drug Alcohol Rev. 2018;37(4):480–486.
  • Rando J, Broering D, Olson JE, Marco C, Evans SB. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201–1204.
  • Townsend T, Blostein F, Doan T, Madson-Olson S, Galecki P, Hutton DW. Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. Int J Drug Policy. 2020;75:1–9.
  • Missouri Department of Health and Senior Services (DHSS). Opioids dashboard. https://health.mo.gov/data/opioids/. Published 2018. Accessed April 29, 2020.
  • MO Rev Stat § 195.206. Missouri Naloxone Standing Order; 2016.
  • Beletsky L, Agrawal A, Moreau B, Kumar P, Weiss-Laxer N, Heimer R. Police training to align law enforcement and HIV prevention: preliminary evidence from the field. Am J Public Health. 2011;101(11):2012–2015.
  • Dunn KE, Barrett FS, Bigelow GE. Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management. Addict Behav. 2018;86:56–60.